A study published in Cancer Cell describes an experimental drug that breaks down this barrier from inside the tumor and lets T cells in to attack. In mice, the drug cleared aggressive pancreatic tumors, stopped breast cancer from spreading and left the animals with long-lasting immune memory. That memory protected against new tumors, including some different types of cancer.
The international study was led by Dr. Seong-Jin Kim and his team of scientists at MedPacto Inc. in Seoul, Korea. Co-author John J. Letterio, M.D., Ph.D., is director of the Angie Fowler Adolescent and Young Adult Cancer Institute at University Hospitals Rainbow Babies & Children’s Hospital and director of the Developmental Therapeutics Program at Case Comprehensive Cancer Center, Case Western Reserve University.